Author:
Londhe Priya,Gutwillig Megan,London Cheryl
Reference125 articles.
1. Masitinib is safe and effective for the treatment of canine mast cell tumors;Hahn;J Vet Intern Med,2008
2. Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excision;London;Clin Cancer Res,2009
3. Cell signaling by receptor tyrosine kinases;Lemmon;Cell,2010
4. New paradigms for the treatment of cancer: the role of anti- angiogenesis agents;Cherrington;Adv Cancer Res,2000
5. Angiogenesis inhibitors in clinical development; where are we now and where are we going?;Eskens;Br J Cancer,2004
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献